Recommendations for the diagnosis, staging and treatment of pre-malignant lesions and pancreatic adenocarcinoma

[1]  Yan-Shen Shan,et al.  Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial , 2016, The Lancet.

[2]  J. Pergolizzi,et al.  Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid‐Induced Constipation: A Responder Analysis of 2 Randomized, Placebo‐Controlled Trials , 2015, Pain practice : the official journal of World Institute of Pain.

[3]  C. Tan,et al.  Systematic review and meta-analysis of the spectrum and outcomes of different histologic subtypes of noninvasive and invasive intraductal papillary mucinous neoplasms. , 2015, Surgery.

[4]  M. Büchler,et al.  Total pancreatectomy for primary pancreatic neoplasms: renaissance of an unpopular operation. , 2015, Annals of surgery.

[5]  J. S. Karlsson,et al.  Pathology reporting of pancreatic cancer following neoadjuvant therapy: challenges and uncertainties. , 2015, Cancer treatment reviews.

[6]  B. Dörken,et al.  Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  D. McMillan,et al.  Towards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow Prognostic Score. , 2014, Cancer treatment reviews.

[8]  K. Van Loon,et al.  Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: A pooled analysis of 7 prospective trials of gemcitabine‐based therapy with or without bevacizumab , 2014, Cancer.

[9]  A. Sahai,et al.  Celiac plexus neurolysis in the management of unresectable pancreatic cancer: when and how? , 2014, World journal of gastroenterology.

[10]  Jae Woo Park,et al.  Mucinous cystic neoplasm of the pancreas: is surgical resection recommended for all surgically fit patients? , 2014, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[11]  A. Seicean.  Celiac plexus neurolysis in pancreatic cancer: the endoscopic ultrasound approach. , 2014, World journal of gastroenterology.

[12]  D. Sahani,et al.  Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association. , 2014, Gastroenterology.

[13]  J. Sastre,et al.  Outcome Quality Standards in Pancreatic Oncologic Surgery , 2014, Annals of Surgical Oncology.

[14]  P. Gascón,et al.  Clinical evaluation and optimal management of cancer cachexia. , 2013, Critical reviews in oncology/hematology.

[15]  K. Gurusamy,et al.  Meta‐analysis of randomized clinical trials on safety and efficacy of biliary drainage before surgery for obstructive jaundice , 2013, The British journal of surgery.

[16]  David Goldstein,et al.  Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. , 2013, The New England journal of medicine.

[17]  K. Lillemoe,et al.  Branch Duct Intraductal Papillary Mucinous Neoplasms: Does Cyst Size Change the Tip of the Scale? A Critical Analysis of the Revised International Consensus Guidelines in a Large Single-Institutional Series , 2013, Annals of surgery.

[18]  H. Friess,et al.  European experts consensus statement on cystic tumours of the pancreas. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[19]  Bechien U. Wu,et al.  Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[20]  C. Verbeke.  Resection margins in pancreatic cancer. , 2013, The Surgical clinics of North America.

[21]  C. F. Fernandez-del Castillo,et al.  Pancreatic cystic neoplasms: management and unanswered questions. , 2013, Gastroenterology.

[22]  D. Goldstein,et al.  Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  C. Verbeke,et al.  Survey of UK histopathologists’ approach to the reporting of resection specimens for carcinomas of the pancreatic head , 2013, Journal of Clinical Pathology.

[24]  L. Wiebe,et al.  Supportive care of the patient with advanced pancreatic cancer. , 2013, Oncology.

[25]  C. la Vecchia,et al.  European cancer mortality predictions for the year 2014. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  J. Berlin,et al.  Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design , 2013, Annals of Surgical Oncology.

[27]  A. Ruzzenente,et al.  Role of Preoperative Biliary Drainage in Jaundiced Patients Who Are Candidates for Pancreatoduodenectomy or Hepatic Resection: Highlights and Drawbacks , 2013, Annals of surgery.

[28]  Steven P. Cohen,et al.  The Effectiveness of Repeat Celiac Plexus Neurolysis for Pancreatic Cancer: A Pilot Study , 2013, Pain practice : the official journal of World Institute of Pain.

[29]  M. Pitman.  Pancreatic cyst fluid triage , 2013, Cancer cytopathology.

[30]  M. Mcphail,et al.  Endoscopic ultrasound guided fine needle aspiration for the diagnosis of pancreatic cystic neoplasms: a meta-analysis. , 2013, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[31]  Jeffrey E. Lee,et al.  Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators , 2012, Cancer.

[32]  T. Ohtsuka,et al.  Management Strategy for Multifocal Branch Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas , 2012, Pancreas.

[33]  N. Valsangkar,et al.  851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital. , 2012, Surgery.

[34]  C. Verbeke,et al.  Resection margin involvement and tumour origin in pancreatic head cancer , 2012, The British journal of surgery.

[35]  Douglas B. Evans,et al.  Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study. , 2012, Gastrointestinal endoscopy.

[36]  Stuart M. Gardos,et al.  Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer , 2012, Cancer.

[37]  A. Maraveyas,et al.  Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer. , 2012, European journal of cancer.

[38]  Priya R Bhosale,et al.  Imaging of pancreatic adenocarcinoma: update on staging/resectability. , 2012, Radiologic clinics of North America.

[39]  Jin-Young Jang,et al.  International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. , 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[40]  Zhe Zhang,et al.  Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. , 2012, Gastroenterology.

[41]  M. Bibbo,et al.  Targeted cyst wall puncture and aspiration during EUS-FNA increases the diagnostic yield of premalignant and malignant pancreatic cysts. , 2012, Gastrointestinal endoscopy.

[42]  M. Koch,et al.  Arterial Resection During Pancreatectomy for Pancreatic Cancer: A Systematic Review and Meta-Analysis , 2011, Annals of surgery.

[43]  David Cella,et al.  Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  D. Loren,et al.  Fully Covered Self-expandable Metal Stents are Effective and Safe to Treat Distal Malignant Biliary Strictures, Irrespective of Surgical Resectability Status , 2011, Journal of clinical gastroenterology.

[45]  Pierre Michel,et al.  FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. , 2011, The New England journal of medicine.

[46]  D. Sahani,et al.  Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes , 2011, Gut.

[47]  G. Lyman.  Venous thromboembolism in the patient with cancer , 2011, Cancer.

[48]  J. Dominguez-Munoz.  Pancreatic exocrine insufficiency: Diagnosis and treatment , 2011, Journal of gastroenterology and hepatology.

[49]  R. Doi,et al.  Clinicopathological Features and Prognosis of Mucinous Cystic Neoplasm With Ovarian-Type Stroma: A Multi-Institutional Study of the Japan Pancreas Society , 2011, Pancreas.

[50]  J. Werner,et al.  Role of serum carbohydrate antigen 19‐9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas , 2011, The British journal of surgery.

[51]  Jin‐Young Jang,et al.  Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[52]  C. Pilarsky,et al.  Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment. , 2010, The oncologist.

[53]  J. McNamee,et al.  Long-term results of percutaneous transhepatic cholangiographic drainage for palliation of malignant biliary obstruction. , 2010, Journal of palliative medicine.

[54]  M. C. Mateo,et al.  Protocolo de tallado, estudio e informe anatomopatológico de las piezas de duodenopancreatectomía cefálica por carcinoma de páncreas , 2010 .

[55]  S. Park,et al.  Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. , 2010, Radiology.

[56]  H. Friess,et al.  Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. , 2010, JAMA.

[57]  M. Kanda,et al.  Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas. , 2010, Surgery.

[58]  E. Girela,et al.  [Recommendations for diagnosis, staging and treatment of pancreatic cancer (Part II)]. , 2010, Medicina clinica.

[59]  B. Dörken,et al.  A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy: Final results of the CONKO-004 trial. , 2010 .

[60]  S. Noble,et al.  Epidemiology and pathophysiology of cancer-associated thrombosis , 2010, British Journal of Cancer.

[61]  Tibor Schuster,et al.  Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages , 2010, PLoS medicine.

[62]  M. Mino‐Kenudson,et al.  Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[63]  I. Esposito,et al.  Pathological Reporting and Staging Following Pancreatic Cancer Resection , 2010 .

[64]  H. Ueno,et al.  A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer , 2009, British Journal of Cancer.

[65]  K. Lillemoe,et al.  Surgical Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement , 2009, Annals of Surgical Oncology.

[66]  B. Chauffert,et al.  Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[67]  F. Que,et al.  Incidence, Prevalence, and Management of Intraductal Papillary Mucinous Neoplasm in Olmsted County, Minnesota, 1984-2005: A Population Study , 2008, Pancreas.

[68]  M. Mino‐Kenudson,et al.  Mucinous Cystic Neoplasm of the Pancreas is Not an Aggressive Entity: Lessons From 163 Resected Patients , 2008, Annals of surgery.

[69]  Joshua A. Waters,et al.  Intraductal Papillary Mucinous Neoplasms: Predictors of Malignant and Invasive Pathology , 2007, Annals of surgery.

[70]  M. Mino‐Kenudson,et al.  Branch-Duct Intraductal Papillary Mucinous Neoplasms: Observations in 145 Patients Who Underwent Resection , 2007 .

[71]  E. Kuipers,et al.  Effects of abdominal hot compresses on indocyanine green elimination – a randomized cross over study in healthy subjects , 2007, BMC gastroenterology.

[72]  Laura H. Tang,et al.  Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. , 2007, Journal of the American College of Surgeons.

[73]  Peter Neuhaus,et al.  Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. , 2007, JAMA.

[74]  Christopher H. Crane,et al.  Pancreaticoduodenectomy with vascular resection: margin status and survival duration , 2004, Journal of Gastrointestinal Surgery.

[75]  P. Ruszniewski,et al.  Long-term Outcome of Biliary and Duodenal Stents in Palliative Treatment of Patients with Unresectable Adenocarcinoma of the Head of Pancreas , 2006, The American Journal of Gastroenterology.

[76]  P. Bedossa,et al.  Frozen Sectioning of the Pancreatic Cut Surface During Resection of Intraductal Papillary Mucinous Neoplasms of the Pancreas Is Useful and Reliable: A Prospective Evaluation , 2005, Annals of surgery.

[77]  R. Hruban,et al.  Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study , 2005, Virchows Archiv.

[78]  A. Holt,et al.  Palliation of patients with malignant gastroduodenal obstruction with self-expanding metallic stents: the treatment of choice? , 2004, Gastrointestinal endoscopy.

[79]  M. Farnell,et al.  Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[80]  Steven Piantadosi,et al.  Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[81]  K. Campbell,et al.  Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Updated Experience , 2004, Annals of surgery.

[82]  Elizabeth Lee-Lewandrowski,et al.  Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. , 2004, Gastroenterology.

[83]  J. Ayuso,et al.  Preoperative Staging and Tumor Resectability Assessment of Pancreatic Cancer: Prospective Study Comparing Endoscopic Ultrasonography, Helical Computed Tomography, Magnetic Resonance Imaging, and Angiography , 2004, American Journal of Gastroenterology.

[84]  B. Petersen,et al.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. , 2002, Gastroenterology.

[85]  J. Cubiella,et al.  Prognostic factors in nonresectable pancreatic adenocarcinoma: a rationale to design therapeutic trials , 1999, American Journal of Gastroenterology.

[86]  D. V. Von Hoff,et al.  Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.